Will oral semaglutide be a game-changer in the management of type 2 diabetes in primary care?
Sign Up to like & getrecommendations! Published in 2020 at "Primary care diabetes"
DOI: 10.1016/j.pcd.2020.07.011
Abstract: GLP-1 receptor agonists (GLP-1RAs) are recommended for patients with type 2 diabetes (T2D), particularly those at high cardiovascular risk. Oral semaglutide is the first oral GLP-1RA. In clinical trials, oral semaglutide 14 mg reduced mean… read more here.
Keywords: game changer; primary care; semaglutide game; type diabetes ... See more keywords